Search


 
Results 31 - 40 of about 80 for "FDA update".

Continuous glucose monitoring system approved to direct ...

The G5 Mobile Continuous Glucose Monitoring System is now approved for patients and clinicians to use results directly from the device to make diabetes ...

Another weight loss drug approved | ACP Diabetes Monthly

A combination of phentermine and topiramate extended-release (Qsymia) was recently approved by the FDA as an addition to a reduced-calorie diet ...

October 12, 2012 | ACP Diabetes Monthly

... Pre-established goals and a good admission history can improve their care. FDA update. Another weight loss drug approved. ...

New indication approved for empagliflozin | ACP Diabetes ...

Empagliflozin (Jardiance) is approved for a new indication—to reduce the risk of cardiovascular death in adults with type 2 diabetes and cardiovascular ...

Alert on canagliflozin and amputations | ACP Diabetes ...

An ongoing clinical trial found an increase in leg and foot amputations, mostly affecting the toes, in patients treated with canagliflozin (Invokana, Invokamet ...

Hemoglobin A1c test approved for diagnosis | ACP Diabetes ...

The FDA recently approved the first hemoglobin A1c (HbA1c) test specifically labeled for diagnosing diabetes.

August 9, 2013 | ACP Diabetes Monthly

... to episodes of hyperglycemia. FDA update. Hemoglobin A1c test approved for diagnosis. The FDA recently approved the ...

Liraglutide gets new cardiovascular indication | ACP Diabetes ...

The FDA approved a new indication for liraglutide to reduce the risk of myocardial infarction, stroke, and cardiovascular death in adults with type 2 ...

March 13, 2015 | ACP Diabetes Monthly

... goals, according to a study. FDA update. New labels warn against sharing multi-dose insulin pens. In an effort to reduce ...

September 16, 2016 | ACP Diabetes Monthly

... intervention to improve HbA1c testing. FDA update. Glucagon recalled due to detaching needles. Six batches of GlucaGen HypoKit ...

Result Page: < Previous  1 2 3 4 5 6 7 8  Next >